BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36087034)

  • 21. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
    Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
    Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis induction in human prostate cancer cells related to the fatty acid metabolism by wogonin-mediated regulation of the AKT-SREBP1-FASN signaling network.
    Sun Y; Guo W; Guo Y; Lin Z; Wang D; Guo Q; Zhou Y
    Food Chem Toxicol; 2022 Nov; 169():113450. PubMed ID: 36208653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CircPLK1 Acts as a Carcinogenic Driver to Promote the Development of Malignant Pleural Mesothelioma by Governing the miR-1294/HMGA1 Pathway.
    Zhang Q; Wang Z; Cai H; Guo D; Xu W; Bu S; Jiang Y
    Biochem Genet; 2022 Oct; 60(5):1527-1546. PubMed ID: 35050425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer.
    Du T; Sikora MJ; Levine KM; Tasdemir N; Riggins RB; Wendell SG; Van Houten B; Oesterreich S
    Breast Cancer Res; 2018 Sep; 20(1):106. PubMed ID: 30180878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells.
    Sharma P; Yadav P; Jain RP; Bera AK; Karunagaran D
    Life Sci; 2022 Feb; 291():120268. PubMed ID: 34973275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer.
    Zhou C; Qian W; Li J; Ma J; Chen X; Jiang Z; Cheng L; Duan W; Wang Z; Wu Z; Ma Q; Li X
    J Exp Clin Cancer Res; 2019 Jul; 38(1):302. PubMed ID: 31296258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
    Cao XP; Cao Y; Zhao H; Yin J; Hou P
    Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The high mobility group A1 gene: transforming inflammatory signals into cancer?
    Resar LM
    Cancer Res; 2010 Jan; 70(2):436-9. PubMed ID: 20068164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway.
    Kuo CY; Chang YC; Chien MN; Jhuang JY; Hsu YC; Huang SY; Cheng SP
    Endocr Relat Cancer; 2021 Dec; 29(2):47-58. PubMed ID: 34821220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibitory effect of trans-10,cis-12 conjugated linoleic acid on sterol regulatory element binding protein-1 activation in bovine mammary epithelial cells involved reduced proteasomal degradation of insulin-induced gene-1.
    Chen L; Lengi AJ; Corl BA
    J Dairy Sci; 2021 Oct; 104(10):11306-11316. PubMed ID: 34275626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Rocha F; Matros E; Redston M; Whang E
    Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells.
    Panneerselvam J; Srivastava A; Muralidharan R; Wang Q; Zheng W; Zhao L; Chen A; Zhao YD; Munshi A; Ramesh R
    Oncotarget; 2016 Oct; 7(43):70247-70263. PubMed ID: 27602961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apelin protects against liver X receptor-mediated steatosis through AMPK and PPARα in human and mouse hepatocytes.
    Huang J; Kang S; Park SJ; Im DS
    Cell Signal; 2017 Nov; 39():84-94. PubMed ID: 28821440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGA1 promotes gastric cancer growth and metastasis by transactivating SUZ12 and CCDC43 expression.
    Yang Q; Wang Y; Li M; Wang Z; Zhang J; Dai W; Pei M; Hong L; Xiao Y; Hu H; Li J; Lin J; Wu X; Chen Y; Huang M; Li A; Liu S; Tang W; Xiang L; Wang J
    Aging (Albany NY); 2021 Jun; 13(12):16043-16061. PubMed ID: 34167089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1.
    Zhang X; Tao T; Liu C; Guan H; Huang Y; Xu B; Chen M
    Oncol Rep; 2016 Jul; 36(1):376-82. PubMed ID: 27175617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis.
    Li W; Tai Y; Zhou J; Gu W; Bai Z; Zhou T; Zhong Z; McCue PA; Sang N; Ji JY; Kong B; Jiang J; Wang C
    Cell Cycle; 2012 Jun; 11(12):2348-58. PubMed ID: 22672904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.
    Di Cello F; Shin J; Harbom K; Brayton C
    Biochem Biophys Res Commun; 2013 Apr; 434(1):70-4. PubMed ID: 23545254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial-Mesenchymal Transition and Stemness in Esophageal Carcinoma.
    Huang CM; Huang CS; Hsu TN; Huang MS; Fong IH; Lee WH; Liu SC
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861383
    [No Abstract]   [Full Text] [Related]  

  • 39. Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1.
    Guo J; Fang W; Sun L; Lu Y; Dou L; Huang X; Sun M; Pang C; Qu J; Liu G; Li J
    Oncotarget; 2016 Jun; 7(24):36207-36219. PubMed ID: 27166182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion.
    Zhong J; Liu C; Zhang QH; Chen L; Shen YY; Chen YJ; Zeng X; Zu XY; Cao RX
    Int J Oncol; 2017 May; 50(5):1567-1578. PubMed ID: 28393241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.